Pacira Pharmaceuticals Inc (NASDAQ:PCRX) - Share price - Overview

Stock Report

Pacira Pharmaceuticals Inc PCRX

Last Price
$35.80

Day Change
-0.25|-0.69%

As of 18/08/2017
16:23:41 EDT | USD
Minimum 15 Minutes Delay.

Last Close36.05
Day Range35.20 - 36.65
Mkt Cap1.44Bil
52-Wk Range29.95 - 58.95
Yield %-
ISINUS6951271005
Volume755,860
P/E-20.94
P/S4.86
P/CF41.86

Share Price

Financials
201420152016
More ...
Income Statement
Revenue197.67249.00276.37
Operating Income-5.179.46-32.02
Net Income-13.721.86-37.95
Basic EPS-0.390.05-1.02
Avg. Diluted Shares Outstanding354137
Balance Sheet
Current Assets214.26252.58243.09
Non Current Assets111.82137.04148.38
Total Assets326.07389.62391.47
Current Liabilities140.01151.6844.84
Total Liabilities154.93171.23172.49
Total Equity171.15218.39218.98
Cash Flow
Operating Cash Flow25.4729.0033.45
Capital Expenditure-21.89-41.27-24.71
Free Cash Flow3.58-12.278.74

In millions, except "Basic EPS". Currency is USD.

Company Profile

Pacira Pharmaceuticals Inc is a specialty and generic drug manufacturing company. The company develops, manufactures, and commercializes pharmaceutical products for use in hospitals and ambulatory surgery centers across the United States.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Stock Style

Small-Growth

Fiscal Year Ends

December

Employees

503
Key Stats
More ...
Price/Earning TTM-21.08
Price/Book5.57
Price/Sales TTM4.82
Rev Growth (3 year avg)47.83
EPS Growth (3 year avg)-
Operating Margin % TTM-11.59
Net Margin % TTM-13.73
ROE TTM-17.35
Debt/Equity0.50
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.